NCT07095309View on ClinicalTrials.gov

Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/ III Colorectal Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

August 30, 2032

Study Completion Date

July 31, 2033

Conditions
Stage II/III Colon CancerBowel Cancer
Interventions
DRUG

Artesunate

Artesunate 200mg PO OD for 14 days prior to colorectal resection surgery

DRUG

Artesunate matching Placebo

Matched placebo PO OD for 14 days prior to colorectal resection surgery

Trial Locations (6)

10990

Hospital Pulau Pinang, Pulau Pinang

47000

Hospital Sungai Buloh, Sungai Buloh

50586

Hospital Kuala Lumpur, Kuala Lumpur

59100

Pusat Perubatan Universiti Malaya, Kuala Lumpur

93586

Hospital Umum Sarawak, Kuching

05460

Hospital Sultanah Bahiyah, Alor Star

Sponsors
All Listed Sponsors
collaborator

Clinical Research Malaysia

UNKNOWN

lead

Metanoic Health Ltd.

INDUSTRY

NCT07095309 - Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/ III Colorectal Cancer | Biotech Hunter | Biotech Hunter